THBD and ischemic stroke: Zhu et al. conducted a multicenter prognostic cohort study of 3532 Chinese ischemic stroke patients, concluding that increased plasma TM levels at baseline were associated with decreased risks of adverse clinical outcomes at 3 months after ischemic stroke, suggesting a protective role of thrombomodulin in the development of ischemic stroke [20].